Emrah ATAY, Gökçe DAĞTEKİN, Sevil Akbulut ZENCİRCİ, Hatice AYGAR, Alaettin ÜNSAL, Didem ARSLANTAŞ

Bü ro Çalışanlarında Kürü Go z Sendromü ve Yaşam Kalitesi: Eskişehir Osmangazi Ü niversitesi O rneg i

Çalışmada, Eskişehir Osmangazi Üniversitesi Tıp Fakültesi hastanesi ve Dekanlığında görev yapan büro çalışanlarında Kuru Göz Sendromu (KGS) sıklığının saptanması, ilişkili olduğu düşünülen bazı faktörlerin incelenmesi ve yaşam kalitesinin değerlendirilmesi amaçlandı. Bu çalışma, Ocak-Nisan 2017 yılında Eskişehir Osmangazi Üniversitesi Tıp Fakültesi Dekanlığı ve Sağlık, Uygulama ve Araştırma Hastanesi’nde görev yapan büro çalışanları arasında gerçekleştirilen kesitsel tipte bir araştırmadır. Çalışmaya katılmayı kabul eden 317 kişi çalışma grubunu oluşturdu. KGS varlığı ve şiddetinin değerlendirilmesinde Oküler Yüzey Hastalık İndeksi ölçeği (OSDİ), sağlıkla ilişkili yaşam kalitesinin değerlendirilmesinde SF-36 yaşam kalitesi ölçeği kullanıldı. OSDİ ölçeğinden 13 ve üzeri puan alanlarda KGS olduğu kabul edildi. Çalışanların 89’u (%28.1) erkek, 228’i (%71.9) ise kadındır. Yaşları 22-63 arasında değişmekte olup, ortalaması 35,86 ± 8,11 yıl idi. Araştırmamızda büro çalışanlarında KGS görülme sıklığı %77.6 (n=246) olarak saptandı. Kadınlarda, hekim tanılı kronik hastalığı olanlarda, sürekli ilaç kullananlarda ve hekim tanılı başka bir göz hastalığı olanlarda KGS sıklığının daha yüksek olduğu saptandı. KGS olanlarda SF-36 yaşam kalitesi ölçeğinin bütün alt alanlarından alınan puan ortalamaları daha düşük idi. (Her alt alan için p≤0.05). OSDİ ölçeğinden alınan puanlar ile SF-36 ölçeğinin tüm alt alanlarından alınan puanlar arasında negatif yönde zayıf bir korelasyon saptandı. Büro çalışanlarında KGS önemli bir sağlık sorunu olduğu ve bu sendromun saptandığı kişilerde yaşam kalitesinin daha kötü olduğu görüldü. KGS’den korunma hususunda hastalık ile ilgili farkındalık ve ekranlı araçların doğru kullanımı ile ilgili bilgilendirme etkinliklerinin düzenlenmesi, hastalığın erken teşhisi için taramaların yapılması ve saptanan olguların uzman hekimlere yönlendirilmesi önerilmektedir.

The Dry Eye Syndrome and Qüality of Life Among Office Workers in Eskişehir Osmangazi Üniversity Hospital

In this study, it was aimed to determine the prevalance of dry eye syndrome and evaluate the relationship with quality of life in the office workers in Eskişehir Osmangazi University Faculty of Medicine. This is a cross-sectional study conducted between January-April 2017 in Eskişehir Osmangazi University Faculty of Medicine. The study group consists of 317 office workers who are employees of Faculty of Medicine. The existence and level of dry eye syndrome was evaluated with The “Ocular Surface Disease Index“ (OSDI) and SF-36 quality of life scale were used to evaluate health-related quality of life. The people who scored 13 or more in OSDI scale were accepted as having dry eye syndrome. Of the employees, 89 (28.1%) were male and 228 (71.9%) were female. The ages ranged from 22 to 63 years, with a mean of 35.86 ± 8.11 years. The prevalence of dry eye syndrome was found as 77.6% (n = 246). The prevalence of dry eye syndrome was found to be higher in women, in patients with clinically diagnosed chronic disease, in continuous-drug use, and in the group having another diagnosed eye disease. The mean scores of all sub-scales of SF-36 quality of life scale were lower in patients with dry eye syndrome. (For each sub-scale p≤0.05). There was a weak negative correlation between the scores obtained from the OSDI scale and the scores obtained from all subfields of the SF-36 scale. Dry eye syndrome is an important health problem and the quality of life was found to be worse in people with this syndrome. It is recommended office workers has to be informed about disease for the prevention and about the correct use of displays. The screening of the office workers for the early diagnosis of the disease and directing the identified cases to the specialist physicians are also important.

PDF

___

1. Foulks G, Lemp M, Jester J, Sutphin J, Murube J, Novack GJOS. report of the international dry eye workshop (DEWS). 2007;5:65-204.
2. Ding J, Sullivan DA. Aging and dry eye disease. Exp Gerontol. 2012;47:483-90.
3. Utine CA. Kuru Göz Oluşum Mekanizması ve Sınıflandırılması. MN Oftalmoloji 2016;23:1-8
4. Viso E, Rodriguez-Ares MT, Gude F. Prevalence of and associated factors for dry eye in a Spanish adult population (the Salnes Eye Study). Ophthalmic Epidemiol. 2009;16:15-21.
5. Moss SE, Klein R, Klein BE. Prevalence of and risk factors for dry eye syndrome. Arch Ophthalmol. 2000;118:1264-8.
6. Paulsen AJ, Cruickshanks KJ, Fischer ME, et al. Dry eye in the beaver dam offspring study: prevalence, risk factors, and health-related quality of life. Am J Ophthalmol. 2014;157:799-806.
7. Ang RT, Dartt DA, Tsubota K. Dry eye after refractive surgery. Curr Opin Ophthalmol. 2001;12:318-22
8. Schaumberg DA, Dana R, Buring JE, Sullivan DA. Prevalence of dry eye disease among US men: estimates from the Physicians' Health Studies. Arch Ophthalmol. 2009;127:763-8.
9. Schaumberg DA, Sullivan DA, Buring JE, Dana MR. Prevalence of dry eye syndrome among US women. Am J Ophthalmol. 2003;136:318-26.
10. Farrand KF, Fridman M, Stillman IO, Schaumberg DA. Prevalence of Diagnosed Dry Eye Disease in the United States Among Adults Aged 18 Years and Older. Am J Ophthalmol. 2017;182:90-8.
11. Lin P-Y, Tsai S-Y, Cheng C-Y, Liu J-H, Chou P, Hsu W-M. Prevalence of dry eye among an elderly Chinese population in Taiwan: the Shihpai Eye Study. Ophthalmology. 2003;110:1096-101
12. Yilmaz U, Gokler ME, Unsal A. Dry eye disease and depression-anxiety-stress: A hospital-based case control study in Turkey. Pak J Med Sci. 2015;31:626-31.
13. Kırağ N, Temel AB. Yaşlı Bireylerde Kuru Göz Semptomu Sıklığı ve İlişkili Faktörler. Anadolu Hemşirelik ve Sağlık Bilimleri Dergisi. 2016;19:243-51
14. Miljanović B, Dana R, Sullivan DA, Schaumberg DA. Impact of dry eye syndrome on vision-related quality of life. Am J Ophthalmol. 2007;143:409- 15.
15. Kawashima M, Uchino M, Yokoi N, Uchino Y, Dogru M, Komuro A, et al. The association of sleep quality with dry eye disease: the Osaka study. Clinical ophthalmology (Auckland, NZ). 2016;10:1015.
16. Tounaka K, Yuki K, Kouyama K, Abe T, Tsubota K, Kawabe H, et al. Dry Eye Disease Is Associated with Deterioration of Mental Health in Male Japanese University Staff. Tohoku J Exp Med. 2014;233:215-20.
17. Salib GM, McDonald MB, Smolek M. Safety and efficacy of cyclosporine 0.05% drops versus unpreserved artificial tears in dry-eye patients having laser in situ keratomileusis. J Cataract Refr Surg. 2006;32:772-8.
18. Gayton JL. Etiology, prevalence, and treatment of dry eye disease. Clinical ophthalmology (Auckland, NZ). 2009;3:405.
19. Uchino M, Uchino Y, Dogru M, Kawashima M, Yokoi N, Komuro A, et al. Dry eye disease and work productivity loss in visual display users: the Osaka study. Am J Ophthalmol. 2014;157:294- 300.
20. Eskişehir Osmangazi Üniversitesi. Fakülteler, 2018 Available from: https://ogu.edu.tr/Icerik/Index/24/fakulteler. Erişim Tarihi: [20.11.2018].
21. Bakkar MM, Shihadeh WA, Haddad MF, Khader YS. Epidemiology of symptoms of dry eye disease (DED) in Jordan: A cross-sectional non-clinical population-based study. Contact Lens and Anterior Eye. 2016;39:197-202.
22. Paulsen AJ, Cruickshanks KJ, Fischer ME, Huang G-H, Klein BE, Klein R, et al. Dry eye in the beaver dam offspring study: prevalence, risk factors, and health-related quality of life. Am J Ophthalmol. 2014;157:799-806.
23. Barabino S, Labetoulle M, Rolando M, Messmer EM. Understanding symptoms and quality of life in patients with dry eye syndrome. The ocular surface. 2016;14:365-76.
24. Galor A, Feuer W, Lee DJ, Florez H, Carter D, Pouyeh B, et al. Prevalence and risk factors of dry eye syndrome in a United States veterans affairs population. Am J Ophthalmol. 2011;152:377-84.
25. Özcura F, Aydin S, Helvaci MR. Ocular surface disease index for the diagnosis of dry eye syndrome. Ocul Immunol Inflamm. 2007;15(5):389-93.
26. Huang J-F, Zhang Y, Rittenhouse KD, Pickering EH, McDowell MT. Evaluations of tear protein markers in dry eye disease: repeatability of measurement and correlation with disease. Invest Ophthalmol Vis Sci. 2012;53:4556-64.
27. Ware Jr JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36): I. Conceptual framework and item selection. Medical care. 1992:473-83.
28. Koçyigit H. Kısa Form-36 (KF-36)'nm Türkçe versiyonunun güvenilirligi ve geçerliliği. İlaç ve tedavi dergisi. 1999;12:102-6.
29. Tolonen H, Wolf H, Jakovljevic D, Kuulasmaa K. Review of surveys for risk factors of major chronic diseases and comparability of the results. EHRM Project Oslo. 2002.
30. Miljanović B, Dana R, Sullivan DA, Schaumberg DA. Impact of dry eye syndrome on vision-related quality of life. Am J Ophthalmol. 2007;143:409- 15.
31. McCarty CA, Bansal AK, Livingston PM, Stanislavsky YL, Taylor HR. The epidemiology of dry eye in Melbourne, Australia. Ophthalmology. 1998;105:1114-9.
32. Lin P-Y, Tsai S-Y, Cheng C-Y, Liu J-H, Chou P, Hsu W-M. Prevalence of dry eye among an elderly Chinese population in Taiwan: the Shihpai Eye Study. Ophthalmology. 2003;110:1096-101.
33. Moss SE, Klein R, Klein BE. Prevalence of and risk factors for dry eye syndrome. Archives of ophthalmology. 2000;118:1264-8.
34. Yilmaz U, Gokler ME, Unsal A. Dry eye disease and depression-anxiety-stress: A hospital-based case control study in Turkey. Pak J Med Sci. 2015;31:626-31.
35. Janine A. The epidemiology of dry eye disease: report of the epidemiological subcommittee of the international dry eye workshop. Ocul Surf. 2007;5:93-107.
36. Kawashima M, Uchino M, Yokoi N, Uchino Y, Dogru M, Komuro A, et al. The association of sleep quality with dry eye disease: the Osaka study. Clinical ophthalmology (Auckland, NZ). 2016;10:1015.
37. Portello JK, Rosenfield M, Bababekova Y, Estrada JM, Leon A. Computer‐related visual symptoms in office workers. Ophthalmic Physiol Opt. 2012;32:375-82.
38. Schaumberg DA, Sullivan DA, Buring JE, Dana MR. Prevalence of dry eye syndrome among US women. Am J Ophthalmol. 2003;136:318-26.
39. Aydın Akova Y. ve Açıkalın B. Kadınlarda Kuru Göz. MN Oftalmoloji 2016;23:60-3
40. Bingöl N. Kuru Göz Tanılı Hastaların Epidemiyolojik Araştırılması. Uzmanlık Tezi. İstanbul: Okmeydanı Eğitim ve Araştırma Hastanesi; 2009.
41. Uchino M, Schaumberg DA, Dogru M, Uchino Y, Fukagawa K, Shimmura S, et al. Prevalence of dry eye disease among Japanese visual display terminal users. Ophthalmology. 2008;115:1982-8.
42. Lee A, Lee J, Saw S, Gazzard G, Koh D, Widjaja D, et al. Prevalence and risk factors associated with dry eye symptoms: a population based study in Indonesia. British Journal of Ophthalmology. 2002;86:1347-51.
43. Dursun Altınörs D. ve Asena L. Sistemik Hastalıklar ve Kuru Göz. MN Oftalmoloji 2016;23:53-59.
44. Nowak M, Marek B, Kos-Kudła B, Kajdaniuk D, Siemińska L. Tear film profile in patients with active thyroid orbithopathy. Klinika oczna. 2005;107:479-82.
45. Bayer A. ve Özge G. Glokom, Glokom İlaçları ve Kuru Göz. MN Oftalmoloji 2016;23:91-5.
46. Fujishima H, Toda I, Shimazaki J, Tsubota K. Allergic conjunctivitis and dry eye. Br J Ophthalmol. 1996;80:994-7.
47. Knudtson MD, Klein BE, Klein R, Cruickshanks KJ, Lee KE. Age-related eye disease, quality of life, and functional activity. Archives of Ophthalmology. 2005;123:807-14.
48. Schiffman RM, Walt JG, Jacobsen G, Doyle JJ, Lebovics G, Sumner W. Utility assessment among patients with dry eye disease. Ophthalmology. 2003;110:1412-9.
49. Buchholz P, Steeds CS, Stern LS, Wiederkehr DP, Doyle JJ, Katz LM, et al. Utility assessment to measure the impact of dry eye disease. The ocular surface. 2006;4:155-61.
50. Brown MM, Brown GC. Utility assessment and dry eye disease. Ophthalmology. 2004;4:852-3.